aTyr Pharma | LIFE - Sales Revenues

Stock Price
0.82
Daily Change
-0.06 -6.58%
Monthly
-21.52%
Yearly
-78.54%
Q1 Forecast
0.82

aTyr Pharma reported $190K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Ardelyx USD 110.33M 12.67M Sep/2025
aTyr Pharma USD 190K 2.03M Sep/2025
Biogen USD 2.28B 250M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
CSL USD 8.33B 4.79B Dec/2025
Curis USD 2.55M 460K Jun/2024
Galapagos EUR 900.82M 835.52M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Grifols EUR 2.34B 159.69M Mar/2026
Novartis USD 13.91B 144M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025
Xoma USD 25K 5M Sep/2024